Kentaro Ohki

2.2k total citations
48 papers, 499 citations indexed

About

Kentaro Ohki is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Kentaro Ohki has authored 48 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hematology, 20 papers in Public Health, Environmental and Occupational Health and 12 papers in Molecular Biology. Recurrent topics in Kentaro Ohki's work include Acute Myeloid Leukemia Research (21 papers), Acute Lymphoblastic Leukemia research (20 papers) and Lymphoma Diagnosis and Treatment (9 papers). Kentaro Ohki is often cited by papers focused on Acute Myeloid Leukemia Research (21 papers), Acute Lymphoblastic Leukemia research (20 papers) and Lymphoma Diagnosis and Treatment (9 papers). Kentaro Ohki collaborates with scholars based in Japan, United States and Taiwan. Kentaro Ohki's co-authors include Yasuhide Hayashi, Yoshinori Nishino, Hyuntae Park, Nobutaka Kiyokawa, Manabu Sotomatsu, Norio Shiba, Yusuke Hara, Keizo Horibe, Tomohiko Taki and Souichi Adachi and has published in prestigious journals such as Blood, The Journal of Immunology and Environment International.

In The Last Decade

Kentaro Ohki

43 papers receiving 494 citations

Peers

Countries citing papers authored by Kentaro Ohki

Since Specialization

Citations

This map shows the geographic impact of Kentaro Ohki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kentaro Ohki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kentaro Ohki more than expected).

Fields of papers citing papers by Kentaro Ohki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kentaro Ohki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kentaro Ohki. The network helps show where Kentaro Ohki may publish in the future.

Co-authorship network of co-authors of Kentaro Ohki

This figure shows the co-authorship network connecting the top 25 collaborators of Kentaro Ohki. A scholar is included among the top collaborators of Kentaro Ohki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kentaro Ohki. Kentaro Ohki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Adverse prognostic impact of <i>KIT</i> exon 17 mutations despite negative flow cytometric measurable residual disease in pediatric acute myeloid leukemia with <i>RUNX1::RUNX1T1</i> 2024 ·Haematologica ·Shota Kato, Shin‐ichi Tsujimoto, Jun Matsubayashi, Shotaro Iwamoto, Hidefumi Hiramatsu, Yusuke Okuno, (unknown), Kentaro Ohki, Takao Deguchi, Nobutaka Kiyokawa, Motohiro Kato, Junko Takita, Shiro Tanaka, Souichi Adachi, Daisuke Tomizawa, Norio Shiba	0
2	Rituximab-combined anthracycline-free chemotherapy in newly diagnosed paediatric and adolescent patients with non-high-risk aggressive mature B cell lymphoma: protocol for a single-arm, open-label, multicentre, phase II study (the Japan Children’s Cancer Group Multicentre Trial, JPLSG B-NHL-20) 2024 ·BMJ Open ·Masahiro Sekimizu, Reiji Fukano, Yuhki Koga, Tetsuo Mitsui, Naoto Fujita, Takeshi Mori, (unknown), Makito Tanaka, Kentaro Ohki, (unknown), Atsuko Nakazawa, Tetsuya Mori, Ryōji Kobayashi, Hiroya Hashimoto, Akiko Saito, (unknown)	2
3	High DOCK1 expression identifies a distinct prognostic subgroup of pediatric acute myeloid leukemia: Results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML‐05 trial 2024 ·Pediatric Blood & Cancer ·(unknown), Shin‐ichi Tsujimoto, (unknown), Tomoko Kawai, Kentaro Ohki, Yusuke Hara, Genki Yamato, Reo Tanoshima, Daisuke Tomizawa, Akira Shimada, Keizo Horibe, Souichi Adachi, Takashi Taga, Akio Tawa, Yasuhide Hayashi, Shuichi Ito, Norio Shiba	1
4	Rituximab with standard LMB chemotherapy in pediatric high‐risk mature B‐cell non‐Hodgkin lymphoma: A report from the JPLSG B‐NHL14 trial 2023 ·European Journal Of Haematology ·Tetsuya Mori, Tomoo Osumi, Akiko Kada, Kentaro Ohki, Yuhki Koga, Reiji Fukano, Naoto Fujita, Tetsuo Mitsui, (unknown), (unknown), Akiko Saito, Atsuko Nakazawa, Ryōji Kobayashi, Masahiro Sekimizu	1
5	Clinicopathological features and prognostic significance of programmed death ligand 1 in pediatric ALK-positive anaplastic large cell lymphoma: results of the ALCL99 treatment in Japan 2021 ·Human Pathology ·(unknown), Atsuko Nakazawa, Masahiro Sekimizu, Tetsuya Mori, Tomoo Osumi, Yuka Iijima‐Yamashita, Kentaro Ohki, Nobutaka Kiyokawa, Reiji Fukano, Akiko Saito, Keizo Horibe, Ryōji Kobayashi	3
6	Analysis of the BRAF and MAP2K1 mutations in patients with Langerhans cell histiocytosis in Japan 2020 ·International Journal of Hematology ·(unknown), (unknown), Yoko Shioda, Toshihiko Imamura, Kenichiro Watanabe, Kentaro Ohki, Takako Yoshioka, (unknown), Yuta Kawahara, (unknown), Shinsaku Imashuku, Akira Morimoto	7
7	B-Cell Precursor–Acute Lymphoblastic Leukemia With EBF1-PDGFRB Fusion Treated With Hematopoietic Stem Cell Transplantation and Imatinib: A Case Report and Literature Review 2020 ·Journal of Pediatric Hematology/Oncology ·(unknown), (unknown), (unknown), Naoki Hatakeyama, (unknown), Toshihiko Imamura, Tomoo Osumi, Kentaro Ohki, Nobutaka Kiyokawa, Hiroshi Azuma	5
8	Frequency of Common Copy-Number Variations at 15q11.2q13 in Sperm of Healthy Men 2019 ·Cytogenetic and Genome Research ·Takahiro Kinoshita, Masashi Mikami, Tadayuki Ayabe, Keiko Matsubara, Hiromi Ono, Kentaro Ohki, Maki Fukami, Yûkô Fukui	3
9	The Effect of Interim FDG-PET-guided Response-Adapted Therapy in Pediatric Patients with Hodgkin's Lymphoma (HL-14) : Protocol for a Phase II Study. 2018 ·PubMed ·Yuhki Koga, Shingo Baba, Reiji Fukano, Katsumasa Nakamura, Toshinori Soejima, Naoko Maeda, (unknown), Junichi Ueyama, Tetsuo Mitsui, Takeshi Mori, Tomoo Osumi, Masahiro Sekimizu, Kentaro Ohki, Fumiko Tanaka, (unknown), Naoto Fujita, Tetsuya Mori, Akiko Saito, Akiko Kada, Ryōji Kobayashi	0
10	Effect of Age on the Prognosis of Molecular Abnormalities in Pediatric Acute Myeloid Leukemia 2018 ·Blood ·Yusuke Hara, Norio Shiba, Genki Yamato, Kentaro Ohki, Manabu Sotomatsu, Ken Tabuchi, Daisuke Tomizawa, Tomohiko Taki, Akitoshi Kinoshita, Nobutaka Kiyokawa, Hirokazu Arakawa, Masabumi Shibuya, Takashi Taga, Akio Tawa, Keizo Horibe, Souichi Adachi, Yasuhide Hayashi	0
11	Efficacy and safety of oral propranolol for infantile hemangioma in Japan 2017 ·Pediatrics International ·Tsuyoshi Kaneko, Satoru Sasaki, Naoko Baba, Katsuyoshi Koh, Kiyoshi Matsui, Hiroyuki Ohjimi, Nobukazu Hayashi, Atsuko Nakano, Kentaro Ohki, Yoshihiro Kuwano, Akira Morimoto, Zenshiro Tamaki, (unknown), Kazuo Kishi, Tomoki Oyama, Atsushi Satō, Rumiko Kato, Takeshi Higuchi	14
12	Comprehensive Immunophenotyping Panel in Japan Enables to Detect Rare Subtypes in Childhood Leukemia 2017 ·Blood ·Takao Deguchi, Nobutaka Kiyokawa, Kentaro Ohki, Yoshiko Hashii, Atsushi Manabe, Souichi Adachi, Akiko Saito, Keizo Horibe	0
13	Genome‐wide approach to identify second gene targets for malignant rhabdoid tumors using high‐density oligonucleotide microarrays 2014 ·Cancer Science ·Junko Takita, Yuyan Chen, Motohiro Kato, Kentaro Ohki, Yusuke Sato, Shigeru Ohta, Kanji Sugita, Riki Nishimura, N. Hoshino, Masafumi Seki, Masashi Sanada, Akira Oka, Yasuhide Hayashi, Seishi Ogawa	9
14	WT1 mutation in pediatric patients with acute myeloid leukemia: a report from the Japanese Childhood AML Cooperative Study Group 2013 ·International Journal of Hematology ·Hirozumi Sano, Akira Shimada, Ken Tabuchi, Tomohiko Taki, Chisato Murata, (unknown), Kentaro Ohki, Manabu Sotomatsu, Souichi Adachi, Akio Tawa, Ryōji Kobayashi, Keizo Horibe, Masahiro Tsuchida, Ryoji Hanada, Ichiro Tsukimoto, Yasuhide Hayashi	12
15	Mutational analyses of the ATP6V1B1 and ATP6V0A4 genes in patients with primary distal renal tubular acidosis 2013 ·Nephrology Dialysis Transplantation ·Kenichiro Miura, Takashi Sekine, Kazuhiro Takahashi, Junko Takita, Yutaka Harita, Kentaro Ohki, Hyuntae Park, Yasuhide Hayashi, Asako Tajima, Masayuki Ishihara, (unknown), (unknown), Takashi Igarashi	22
16	Liver disease is frequently observed in Down syndrome patients with transient abnormal myelopoiesis 2013 ·International Journal of Hematology ·(unknown), Manabu Sotomatsu, Kentaro Ohki, (unknown), Kenichi Maruyama, Tomio Kobayashi, Akira Nishi, (unknown), Takeshi Takagi, Yasuhide Hayashi	19
17	Aberrations of NEGR1 on 1p31 and MYEOV on 11q13 in neuroblastoma 2011 ·Cancer Science ·Junko Takita, Yuyan Chen, (unknown), Masashi Sanada, (unknown), Kentaro Ohki, Riki Nishimura, Ryoji Hanada, Takashi Igarashi, Yasuhide Hayashi, Seishi Ogawa	30
18	Langerhans cell histiocytosis with multifocal bone lesions: comparative clinical features between single and multi-systems 2009 ·International Journal of Hematology ·(unknown), Shinsaku Imashuku, Naoko Kinukawa, Akinobu Matsuzaki, Toshiyuki Kitoh, Kentaro Ohki, Yoko Shioda, Yukiko Tsunematsu, Toshihiko Imamura, Akira Morimoto	23
19	The carboxyl-terminal region of HIV-1 Nef protein is a cell surface domain that can interact with CD4+ T cells. 1994 ·The Journal of Immunology ·Kaori Otake, Yoichi Robertus Fujii, (unknown), Yoshinori Nishino, Qi Zhong, Koh Fujinaga, Masanori Kameoka, Kentaro Ohki, (unknown)	43
20	Cells surviving infection by human immunodeficiency virus type 1: vif or vpu mutants produce non-infectious or markedly less cytopathic viruses 1992 ·Journal of General Virology ·(unknown), Yoshinori Nishino, Morito Sumiya, Kentaro Ohki, Takao Kimura, Toshiyuki Goto, Masuyo Nakai, M. Kakinuma, Kazuyoshi Ikuta	37

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact